Accused Scientist Reaches Plea Deal

A Chinese researcher working in Wisconsin who was accused of stealing an experimental cancer drug pleads guilty to a lesser charge.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Medical College of Wisconsin Cancer CenterWIKIMEDIA, DBKOVACHThis April, US prosecutors charged Hujuan Zhao, a Chinese researcher at the Medical College of Wisconsin (MCW), with “economic espionage” for allegedly stealing a potential cancer drug and related data on behalf of a university in China. That charge was swiftly dropped, but earlier this month Zhao reached a plea agreement to accept a charge of “accessing a computer without authorization” in a district court in Milwaukee, reported ScienceInsider.

Zhao worked in cancer researcher Marshall Anderson’s lab at MCW. He was about to leave for a new position at Zhejiang University in Hangzhou, China, when he was arrested in March. According to an FBI statement released at the time, Zhao “may have used his employment and position at MCW to illegally acquire patented research material and taken steps to provide that material to Zhejiang University.” Zhao was also accused of copying files without permission from Anderson’s computer and deleting shared files from an MCW computer. Zhao denies any wrongdoing.

Federal prosecutors quickly abandoned the main charge of “economic espionage,” according to ScienceInsider. Instead, Zhao was charged with illegally accessing a computer and lying to a federal agent. (The FBI reported that Zhao failed to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies